ELISA-Based Crossmatching Allowing the Detection of Emerging Donor-Specific Anti-HLA Antibodies through the Use of Stored Donors' Cell Lysates

About forty years ago the complement-dependent crossmatch assay (CDC-CM) was developed as standard procedure in order to select recipients without donor-specific antibodies directed against human leukocyte antigens of their given donors since the negative outcome of pretransplant crossmatching repre...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlaf, G., Stöhr, K., Rothhoff, A., Altermann, W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655030/
https://www.ncbi.nlm.nih.gov/pubmed/26634169
http://dx.doi.org/10.1155/2015/763157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655030/
https://www.ncbi.nlm.nih.gov/pubmed/26634169
http://dx.doi.org/10.1155/2015/763157

Ejemplares similares